We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.92%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.17B
AUM Growth
+$77.9M
(+1.9%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
7.1%
Holding
2,159
New
572
Increased
455
Reduced
482
Closed
650
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$40.7M |
| 2 |
Apple
AAPL
|
+$38.3M |
| 3 |
S&P Global
SPGI
|
+$36.6M |
| 4 |
Factset
FDS
|
+$29.2M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$31.1M |
| 2 |
Rocket Lab Corp
RKLB
|
+$27.8M |
| 3 |
Insmed
INSM
|
+$26.8M |
| 4 |
T-Mobile US
TMUS
|
+$24.5M |
| 5 |
Warner Bros
WBD
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Industrials | 13.87% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 11.72% |
| 5 | Healthcare | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Sabre
SABR
$743M
| $172K | ﹤0.01% |
+93,973
| New | +$222K |
|
1477
Geron
GERN
$930M
| $171K | ﹤0.01% |
+124,796
| New | +$166K |
|
1478
Fluence Energy
FLNC
$1.68B
| $164K | ﹤0.01% |
+15,183
| New | +$127K |
|
|
YALA
1479
Yalla Group
YALA
$824M
| $157K | ﹤0.01% |
+20,921
| New | +$161K |
|
1480
Emergent Biosolutions
EBS
$377M
| $155K | ﹤0.01% |
+17,588
| New | +$137K |
|
1481
Ultrapar
UGP
$6.74B
| $137K | ﹤0.01% |
+33,357
| New | +$113K |
|
1482
Lindblad Expeditions
LIND
$1.95B
| $133K | ﹤0.01% |
+10,416
| New | +$137K |
|
1483
Verastem
VSTM
$547M
| $126K | ﹤0.01% |
14,298
-140,619
| -91% | -$1.05M |
|
1484
Herbalife
HLF
$1.3B
| $126K | ﹤0.01% |
14,937
-46,672
| -76% | -$440K |
|
1485
Smith & Wesson
SWBI
$657M
| $122K | ﹤0.01% |
12,457
-127,288
| -91% | -$1.09M |
|
1486
Prothena Corp
PRTA
$448M
| $119K | ﹤0.01% |
+12,171
| New | +$93.6K |
|
1487
Allot
ALLT
$373M
| $108K | ﹤0.01% |
+10,233
| New | +$86.8K |
|
1488
BBVA Argentina
BBAR
$3.85B
| $108K | ﹤0.01% |
+12,963
| New | +$175K |
|
1489
Fulcrum Therapeutics
FULC
$248M
| $104K | ﹤0.01% |
+11,272
| New | +$81.6K |
|
1490
Under Armour Class C
UA
$2.97B
| $104K | ﹤0.01% |
+21,455
| New | +$120K |
|
1491
New Fortress Energy
NFE
$94.3M
| $103K | ﹤0.01% |
+46,632
| New | +$133K |
|
1492
Maravai LifeSciences
MRVI
$1.01B
| $96.9K | ﹤0.01% |
+33,775
| New | +$86.2K |
|
1493
Savara
SVRA
$1.09B
| $95.7K | ﹤0.01% |
+26,798
| New | +$79.3K |
|
|
IAUX
1494
i-80 Gold Corp
IAUX
$1.11B
| $94.9K | ﹤0.01% |
99,379
-113,294
| -53% | -$82.5K |
|
1495
Empire State Realty Trust
ESRT
$976M
| $93.8K | ﹤0.01% |
+12,239
| New | +$93.6K |
|
1496
Agilon Health
AGL
$1.65B
| $89.8K | ﹤0.01% |
+3,487
| New | +$132K |
|
1497
Clear Channel Outdoor Holdings
CCO
$1.23B
| $88.7K | ﹤0.01% |
56,135
-439,038
| -89% | -$547K |
|
1498
Orion Group Holdings
ORN
$485M
| $87.4K | ﹤0.01% |
+10,501
| New | +$82.8K |
|
1499
Real Brokerage
REAX
$375M
| $84.8K | ﹤0.01% |
+20,294
| New | +$91.6K |
|
|
NGD
1500
DELISTED
New Gold Inc
NGD
| $80.1K | ﹤0.01% |
+11,159
| New | +$60.4K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q3 2025 Portfolio in Review
As of Q3 2025, Y-Intercept (HK) held 2,159 positions worth $4.17B, up 1.9% from $4.09B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Y-Intercept (HK)'s Q3 2025 filing shows 572 new, 455 increased, 482 reduced and 650 closed positions. Its largest new stake was NVIDIA: 233,683 shares worth $43.6M. The largest sale was UnitedHealth, an estimated $31.1M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
- Y-Intercept (HK)'s largest Q3 2025 buy was NVIDIA: 233,683 shares worth $43.6M.
- Y-Intercept (HK) added most to S&P Global in Q3 2025, an estimated $36.6M increase.
- Y-Intercept (HK)'s biggest Q3 2025 reduction was Insmed, cutting an estimated $26.8M.
- Y-Intercept (HK) fully exited UnitedHealth in Q3 2025, selling an estimated $31.1M.
- Y-Intercept (HK)'s ten largest holdings make up 7.1% of its $4.17B portfolio in Q3 2025.
- Y-Intercept (HK) opened 572 new positions and closed 650 in Q3 2025.
- Y-Intercept (HK)'s portfolio value rose 1.9% quarter-over-quarter to $4.17B.
Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.